Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Sep 3, 2025
- Accession no.
- 0001415889-25-023572
- Filed
- Sep 3, 2025
- Trade date
- Sep 2, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $10.5K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | Common Stock | SSaleDisposed | −707 | $1.60 | −$1,131.2 | 385,624 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −1,799 | $1.60 | −$2,878.4 | 383,825 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −1,575 | $1.60 | −$2,520 | 382,250 | Direct | |
| Sep 2, 2025 | Common Stock | SSaleDisposed | −2,462 | $1.60 | −$3,939.2 | 379,788 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.